Home/Filings/4/0001104659-21-139507
4//SEC Filing

Ernst Jennifer 4

Accession 0001104659-21-139507

CIK 0001787740other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 9:11 PM ET

Size

11.5 KB

Accession

0001104659-21-139507

Insider Transaction Report

Form 4
Period: 2021-11-12
Ernst Jennifer
DirectorChief Executive Officer
Transactions
  • Conversion

    Series Seed-2 Convertible Preferred Stock

    2021-11-125,5660 total
    From: 2021-03-01Common Stock (1,391 underlying)
  • Conversion

    Common Stock

    2021-11-12+1,3911,172,891 total
  • Conversion

    Convertible Promissory Note

    2021-11-120 total
    Exercise: $3.75Common Stock (26,986 underlying)
  • Conversion

    Common Stock

    2021-11-12+26,9861,199,877 total
Footnotes (3)
  • [F1]The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date.
  • [F2]On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount.
  • [F3]The Note was scheduled to mature on June 1, 2023.

Issuer

Tivic Health Systems, Inc.

CIK 0001787740

Entity typeother

Related Parties

1
  • filerCIK 0001889915

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 9:11 PM ET
Size
11.5 KB